Page last updated: 2024-10-21

4-aminopyridine and Patency of the Ductus Arteriosus

4-aminopyridine has been researched along with Patency of the Ductus Arteriosus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thébaud, B1
Michelakis, ED1
Wu, XC1
Moudgil, R1
Kuzyk, M1
Dyck, JR1
Harry, G1
Hashimoto, K1
Haromy, A1
Rebeyka, I2
Archer, SL1
Michelakis, E1
Bateson, J1
Olley, P1
Puttagunta, L1
Archer, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Liberal Versus Restrictive Platelet Transfusion for Treatment of Hemodynamically Significant Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates- A Randomized Open Label, Controlled Trial[NCT03022253]Phase 344 participants (Anticipated)Interventional2016-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for 4-aminopyridine and Patency of the Ductus Arteriosus

ArticleYear
Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus.
    Circulation, 2004, Sep-14, Volume: 110, Issue:11

    Topics: 4-Aminopyridine; Adenoviridae; Animals; Animals, Newborn; Ductus Arteriosus; Ductus Arteriosus, Pate

2004
Voltage-gated potassium channels in human ductus arteriosus.
    Lancet (London, England), 2000, Jul-08, Volume: 356, Issue:9224

    Topics: 4-Aminopyridine; Charybdotoxin; Cyclooxygenase Inhibitors; Ductus Arteriosus; Ductus Arteriosus, Pat

2000